InvestorsHub Logo

ShoeGlue

09/03/16 4:58 PM

#155803 RE: GM_FSJ #155799

No. You've misunderstood the PR.

Pretty amazing stuff, this was the result of the control group of 5 people testing white blood cells after the use of Hemaxellerate...

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=124954163

Here's what the company actually said in the PR.

there is no control group which would help us determine if this promising data are a consequence of HemaXellerate treatment

http://www.prnewswire.com/news-releases/regen-biopharma-inc-receives-new-preliminary-hemaxellerate-clinical-data-on-bone-marrow-suppression-from-pan-am-cancer-treatment-center-590299971.html

Without a control, this is a bunk study and lazy research. These 5 people in Tijuana, Mexico could have all been taking other medicines, undergone other treatments, or been exposed to any number of conditions that have caused their reactions. We don't know if HX had anything at all to do with their conditions, without proper controls. You mention a control group... but there was NONE. BMSN says so in the same PR. Have to read carefully. The research is basically incomplete. I hear the cops and judges in that area of the world are on the take. Could researchers affiliated with US penny stock companies possibly behave similarly? Makes a person wonder. JMO. GLTA. Bmsn.